Top 50 Biotech Startup Investors in France (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
127 | France, United States, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $752k–$34M |
|
Seventure Partners
VC Fund
|
37 | France, United States, Germany | Series A, Series B, Seed | Biotechnology, Software, Health Care | $1.1M–$63M |
|
Kurma Partners
VC Fund
|
34 | France, Switzerland, The Netherlands | Series A, Seed, Series B | Health Care, Biotechnology, Pharmaceutical | $2.8M–$98M |
|
GO CAPITAL
VC Fund
|
29 | France, Canada, Israel | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Health Care | $549k–$13M |
|
Sofinnova Partners
VC Fund
|
29 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Karista
VC Fund
|
25 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $768k–$33M |
|
SOSV
VC Fund
|
23 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
Elaia
VC Fund
|
22 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
Idinvest Partners
VC Fund
|
21 | France, United States, Germany | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.4M–$66M |
|
Auriga Partners
VC Fund
|
18 | France, United States, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $2.4M–$38M |
|
Omnes Capital
VC Fund
|
18 | France, Germany, United States | Series A, Series B, Venture - Series Unknown | Biotechnology, Software, Health Care | $3.8M–$46M |
|
Angels Santé
VC Fund
|
16 | France, India, United States | Seed, Venture - Series Unknown, Angel | Health Care, Biotechnology, Medical Device | $664k–$8.2M |
|
Entrepreneurs First
VC Fund
|
15 | United Kingdom, Singapore, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Machine Learning | $54k–$41M |
|
AdBio partners
VC Fund
|
13 | France, Spain, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Eurazeo
VC Fund
|
12 | France, United States, United Kingdom | Venture - Series Unknown, Seed, Series B | Software, Information Technology, Health Care | $3.2M–$156M |
|
Sofimac Investment Managers
VC Fund
|
12 | France, Italy, Austria | Venture - Series Unknown, Seed | Health Care, Biotechnology, Manufacturing | $268k–$8.7M |
|
Crédit Agricole
VC Fund
|
11 | France, United States, Italy | Debt Financing, Seed | Energy, Health Care, Software | $837k–$1.3B |
|
AQUITI Gestion
VC Fund
|
11 | France, United States | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Manufacturing | $531k–$18M |
|
Pontifax
VC Fund
|
11 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
WiSEED
VC Fund
|
10 | France, Norway | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Manufacturing | $392k–$7.8M |
|
IRDI SORIDEC Gestion
VC Fund
|
10 | France, Brazil, Singapore | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Medical | $1.3M–$13M |
|
BNP Paribas Développement
VC Fund
|
9 | France, Germany, The Netherlands | Venture - Series Unknown, Series A, Seed | Software, Health Care, Information Technology | $2M–$43M |
|
Cap Innov'Est
VC Fund
|
9 | France, United States | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical | $706k–$8.3M |
|
BNP Paribas
VC Fund
|
9 | France, United States, United Kingdom | Debt Financing, Post-IPO Debt, Seed | Financial Services, Energy, Renewable Energy | $564k–$2.5B |
|
Kima Ventures
VC Fund
|
9 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $515k–$16M |
|
Inserm Transfert Initiative
VC Fund
|
9 | France, Switzerland, United States | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.1M–$60M |
|
IRDI
VC Fund
|
8 | France | Series A, Venture - Series Unknown, Seed | Health Care, Software, Biotechnology | $757k–$23M |
|
Anaxago
VC Fund
|
8 | France, United States, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, SaaS, Software | $620k–$13M |
|
XAnge
VC Fund
|
8 | France, Germany, Belgium | Seed, Series A, Series B | Software, SaaS, Health Care | $1.1M–$75M |
|
UI Investissement
VC Fund
|
8 | France, Spain, Canada | Private Equity, Series A, Seed | Manufacturing, Software, Health Care | $1.5M–$49M |
|
Octalfa
VC Fund
|
8 | France | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $658k–$4.6M |
|
Demeter
VC Fund
|
8 | France, Germany, Slovenia | Seed, Series A | Manufacturing, Software, AgTech | $1.5M–$27M |
|
Galia Gestion
VC Fund
|
8 | France, United States | Venture - Series Unknown, Series A | Software, Manufacturing, Biotechnology | $849k–$11M |
|
Meusinvest (Noshaq)
VC Fund
|
8 | Belgium, France, Germany | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $137k–$16M |
|
Sham Innovation Santé
VC Fund
|
7 | France | Series B, Series A, Venture - Series Unknown | Biotechnology, Medical Device, Medical | $1.8M–$80M |
|
Caisse d’Epargne
VC Fund
|
7 | France | Debt Financing, Seed | Software, Health Care, Biotechnology | $400k–$169M |
|
Starquest Capital
VC Fund
|
7 | France, Singapore, United States | Seed, Venture - Series Unknown, Series A | Software, Manufacturing, Information Technology | $300k–$20M |
|
Finovam Gestion
VC Fund
|
7 | France, United States | Seed, Series A | Software, Information Technology, Medical | $513k–$18M |
|
Verve Ventures
VC Fund
|
6 | Switzerland, Germany, France | Seed, Series A, Series B | Software, Health Care, Biotechnology | $1.2M–$45M |
|
SOSV SF & NY (Fka IndieBio)
VC Fund
|
6 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Biotechnology, Health Care, Medical | $50k–$5M |
|
Emertec
VC Fund
|
6 | France, Canada, Switzerland | Series A, Venture - Series Unknown, Seed | Energy, Electronics, Biotechnology | $566k–$6.8M |
|
M Capital Partners
VC Fund
|
6 | France, United States, Canada | Venture - Series Unknown, Seed | Health Care, Software, Food and Beverage | $1.1M–$5.6M |
|
Paca Investissement
VC Fund
|
6 | France | Seed, Venture - Series Unknown | Software, Internet, Manufacturing | $325k–$5.7M |
|
InnoBio Fund
VC Fund
|
6 | France, United States | Series A, Series B, Series C | Biotechnology, Therapeutics, Pharmaceutical | $14M–$26M |
|
Pureos Bioventures
VC Fund
|
6 | France, Switzerland, United States | Series A, Series B, Series C | Biotechnology, Therapeutics, Medical | $7.1M–$125M |
|
Crédit Mutuel Innovation
VC Fund
|
6 | France, United States, Belgium | Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $1.9M–$26M |
|
CEA Investissement
VC Fund
|
6 | France, Canada, United States | Seed, Series A | Manufacturing, Energy, Biotechnology | $847k–$21M |
|
HCVC
VC Fund
|
6 | United States, France, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Robotics | $1.4M–$30M |
|
Newfund
VC Fund
|
5 | France, United States, Canada | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $850k–$15M |
|
Bernard Majoie
Angel
|
5 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.3M–$2.7M |
| Access all 1287 investors in France Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1723
- Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$32M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
- WAAT — WAAT operates fast charging stations for electric and rechargeable hybrid vehicles. Its services are aimed at all private sector market segments, including condominiums, lessees, tertiary, and real estate development. The company was founded in 2018 and is based in Paris with sales offices in Malakoff and Bagneux (92).
- Nepsis — AI-powered software and debt advisory for renewable energy developers. Modern financing solutions for small & medium renewable projects.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion under management as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors. The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 275
- Round size: Seed $1.1M–$4.7M; Series A $3.2M–$28M; Series B $3.4M–$63M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
- Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, The Netherlands
Investor stats
- Total investments: 146
- Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $236M in 2024
Portfolio highlights
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementary sectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 144
- Round size: Seed $549k–$7.1M; Series A $2.1M–$13M; Venture - Series Unknown $974k–$9.5M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- SoonGo — SoonGo is a SaaS company that helps businesses manage and optimize vehicle fleets and professional mobility using data and AI.
- Edison IA — Edison IA functions as an artificial intelligence accelerator designed to help small and medium-sized enterprises integrate AI into their business operations. The company provides a structured, multi-phase framework—spanning 30, 60, and 90 days—to guide businesses from initial training to full deployment. It specializes in developing custom, secure AI agents tailored to automate internal processes, analyze data, and optimize specific corporate workflows. Their service includes auditing a company's readiness, training employees, and implementing scalable AI solutions that comply with data privacy standards.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 353
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 162
- Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $3M–$33M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $44M in 2021
Portfolio highlights
- Kynogon — Autodesk game middleware products, including Beast, Navigation, HumanIK and Scaleform, will no longer be available for purchase.
- Advestigo — Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package thatallows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.
- Plasmabiotics — PENTAX Medical PlasmaBiotics: Ultra-fast endoscope reprocessing solutions to improve patient safety and infection prevention.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 241
- Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $154M in 2026
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- RelaiSanté — RelaiSanté provides a digital coordination platform that connects hospitals with home care providers to manage patient return home. The company offers online tools for hospital teams, home help services, independent nurses and territorial health actors to organize care pathways after hospitalization. RelaiSanté enables secure information sharing, task assignment and monitoring of care arrangements between medical and social care stakeholders. Its products include dedicated interfaces for establishments, home care services and independent professionals. The platform supports teams in structuring discharge processes, reducing fragmentation of communication and clarifying responsibilities. RelaiSanté focuses on improving continuity of care between the healthcare facility and the patient’s home environment.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primary investments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting. Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 351
- Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$37M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 128
- Round size: Series A $2.4M–$14M; Series B $3.8M–$33M; Series C $4.4M–$38M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $57M in 2013
Portfolio highlights
- Isocell — Our food supplements are:natural, safe, and clinically proven
- Availpro — D-EDGE empowers 17,000+ hotels to boost revenue with CRS, Booking Engine, Channel Manager, hospitality-focused websites & digital marketing solutions.
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, Germany, United States
Investor stats
- Total investments: 187
- Round size: Series A $4.3M–$41M; Series B $4.4M–$43M; Venture - Series Unknown $3.8M–$46M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely actively investing — fresh fund, raised $132M in 2025
Portfolio highlights
- Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
- Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
- WhiteLab Genomics — Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for greater safety and efficacy.
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 37
- Round size: Seed $1.1M–$4.6M; Angel $687k–$1.3M; Venture - Series Unknown $664k–$8.2M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
- SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Singapore, United States
Investor stats
- Total investments: 485
- Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- ByteAsk — Derisk your AI agents
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets. With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with the necessary investments needed to realize their growth potential. The firm was founded in 1969 and is based in Paris, Ile-de-France, France.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed, Series B
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 386
- Round size: Seed $3.2M–$16M; Series B $17M–$125M; Venture - Series Unknown $7.8M–$156M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely actively investing — fresh fund, raised $2.6B in 2026
Portfolio highlights
- Excelya — Excelya is a contract research organization (CRO) that provides full-service, FSP, and Resourcing solutions.
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefs d’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: France, Italy, Austria
Investor stats
- Total investments: 74
- Round size: Seed $268k–$3.1M; Venture - Series Unknown $556k–$8.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more...Investment focus
- Industry: Energy, Health Care, Software
- Stage:Debt Financing, Seed
- Geography: France, United States, Italy
Investor stats
- Total investments: 184
- Round size: Seed $837k–$6M; Debt Financing $2.1M–$1.3B
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $300M in 2023
Portfolio highlights
- Crelan — Daar wordt u beter van - C'est mieux pour vous
- Bohr Energy — Bohr Energy is an artificial intelligence firm that aims to make the energy market accessible to independent producers.
- Brenus Pharma — Brenus Pharma develops off-the-shelf, next-generation in vivo immunotherapies designed to unlock the immune response against solid tumors.
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors. Up to now, AQUITI GESTION has invested in more than 200 operations contributing to the creation and development of about 150 companies and thousands of jobs. Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 60
- Round size: Seed $531k–$6.5M; Series A $849k–$18M; Venture - Series Unknown $1.2M–$12M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $7.9M in 2010
Portfolio highlights
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- RelaiSanté — RelaiSanté provides a digital coordination platform that connects hospitals with home care providers to manage patient return home. The company offers online tools for hospital teams, home help services, independent nurses and territorial health actors to organize care pathways after hospitalization. RelaiSanté enables secure information sharing, task assignment and monitoring of care arrangements between medical and social care stakeholders. Its products include dedicated interfaces for establishments, home care services and independent professionals. The platform supports teams in structuring discharge processes, reducing fragmentation of communication and clarifying responsibilities. RelaiSanté focuses on improving continuity of care between the healthcare facility and the patient’s home environment.
- CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — The determination of people living with inclusion body myositis inspires our work and strengthens our resolve to advance precision therapies with the potential to change what's possible.
- Crystalys Therapeutics — Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Norway
Investor stats
- Total investments: 34
- Round size: Seed $392k–$3.3M; Series A $1.3M–$7.8M; Venture - Series Unknown $1M–$6.5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 54
- Round size: Seed $1.7M–$5.8M; Series A $3.7M–$13M; Venture - Series Unknown $1.3M–$12M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
- ThIA Santé Mentale —
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions. The firm considers investments in manufacturing, service industries, medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors. BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 151
- Round size: Seed $2M–$7M; Series A $3.9M–$24M; Venture - Series Unknown $3.4M–$43M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United States
Investor stats
- Total investments: 18
- Round size: Seed $706k–$2.8M; Series A $8.2M–$8.3M; Venture - Series Unknown $2.5M–$4.5M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $49M in 2014
Portfolio highlights
- VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
- Opencell Software — Opencell was created in 2015 to leverage an open source telco billing project initiated in 2007 by David Meyer, their current CEO.Their mission is to provide the first agile monetization platform capable of filling the gap between costly and complex legacy billing solutions and the overly simplistic “one size fits all” SaaS solutions that coveronly the most basic requirements.Opencell is now the open source monetization and billing platform with over 40 successful implementations in multiple industries and countries.
- Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
BNP Paribas provides banking, financing, investment, savings, and protection solutions. The Group's three operational divisions are mobilized to support each type of clientele in their growth and development projects including corporate and institutional banking, commercial, personal banking, investment and protection services. The company provide financing and investment services to retail customers, associations, businesses, and corporations.
Show more...Investment focus
- Industry: Financial Services, Energy, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 315
- Round size: Seed $564k–$20M; Post-IPO Debt $40M–$2.5B; Debt Financing $8.5M–$1.8B
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely actively investing — fresh fund, raised $799M in 2025
Portfolio highlights
- Capitolis — Capitolis is the technology company helping to create safer and more vibrant financial markets by unlocking capital constraints and enabling greater access to more diversified capital and investment opportunities. Rooted in advanced technology and deep financial expertise, Capitolis powers groundbreaking financial solutions that drive growth forglobal and regional banks – and institutional investors alike.
- Encompass — Award-winning EC360 CDI platform and EC solutions for fast, flawless, and frictionless corporate client identity validation and verification.
- Power Solutions International — Power Solutions International is a global producer and distributor of a range of high-performance, certified low emission, power systems for original equipment manufacturers of off-highway industrial equipment. The Company's power system configurations range from a basic engine block integrated with appropriate fuel system components tocomplete packaged power systems that include any combination of cooling systems, electronic systems, air intake systems, fuel systems, housings, power takeoff systems, exhaust systems, hydraulic systems, enclosures, brackets, hoses, tubes, and other assembled componentry. The Company's power systems are primarily spark-ignited, running on alternative fuels such as natural gas and propane. The Company designs, develops, manufactures, distributes, and provides after-market support for its power systems. In April 2014, Power Solutions International Inc acquired Professional Power Products Inc.
Kima Ventures is one of the world's most active early-stage investors, investing in 2 to 3 startups per week all over the world; providing founders with funding, network, and support for them to reach the next steps of their journey. The firm invests from seed to Series A, mostly as lead investor but also working alongside other investors; backing ambitious founders who work hard to build awesome things that more and more people use everyday. The company helps them to build a great team, to learn very quickly, to keep the right focus and execute towards growth. Kima takes pride of itself in working side-by-side with entrepreneurs. They claim to understand that fundraising is only one step in the company’s journey, that’s why they take quick decisions and make the fundraising process as smooth as possible so the founders can get back to the work of building their business. Kima considers itself not only an investor, but a network of founders and experts sharing a pay it forward mindset. Headquartered in Paris with an office in London, the company was founded and backed by Xavier Niel, founder of Iliad and supporter of entrepreneurs through such projects as 42, Station F and 101projets. Over the last 5 years Kima has invested in over 400 startups in 24 different countries.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 772
- Round size: Seed $515k–$5.5M; Pre-Seed $591k–$3.8M; Series A $1.2M–$16M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Hoora — Hoora is a mobile gaming platform that offers an instant, scrollable feed of over 200 casual and arcade mini-games playable without downloads or waiting.
- Verso — Verso is an AI-powered qualitative market research platform that automates consumer insights at scale. It uses adaptive AI to conduct 1-on-1 video or voice interviews with consumers worldwide, turning open-ended conversations into structured, actionable insights in under a week.
- Netsec — Professional cybersecurity and managed IT services to protect your business 24/7.
Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, Switzerland, United States
Investor stats
- Total investments: 23
- Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.2M–$60M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
- VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity. IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creation phase, development or transmission, with intervention tickets from equity € 100000 to € 5000000. Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR: - IRDI, created in 1981 to foster industrial growth companies based in the South West of France - MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées - IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companies In 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: France
Investor stats
- Total investments: 46
- Round size: Seed $757k–$9.2M; Series A $1.6M–$23M; Venture - Series Unknown $1.3M–$23M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
- Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Anaxago is a brand new crowdfunding platform dedicated to innovative companies. Anaxago aims at changing the traditional equity capital investment model. Their goal is to forget about the capitalistic-only and go for a truly sharing and participative investment model. Thanks to Anaxago, entrepreneurs can benefit from the financial support oftheir investors but also learn from the shareholders' experience, expertise and network. Each investor can take an active part to the company life and so be a part of a lively entrepreneurial adventure.They offer a small range of companies each month to their investors community. Startups and small companies are chosen with good care and have to go through a whole process of financial analysis. They also prefer to select companies with a real innovative value added. With Anaxago, young and small companies can find funding and support to grow and develop. They give them a chance to be the actors of tomorrow's growth and reboost their economy.Since its launch, Anaxago gathered 100 000 members and invested more than 130M€ funding more than 200 businesses.
Show more...Investment focus
- Industry: Biotechnology, SaaS, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United States, Belgium
Investor stats
- Total investments: 47
- Round size: Seed $620k–$2.7M; Series A $1.3M–$13M; Venture - Series Unknown $1.5M–$3.3M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- Posos — Posos is a clinical support platform optimizing healthcare professionals’ decisions at every step of the patient journey thanks to an AI-based cross-referencing search engine. Posos allows healthcare professionals to conduct simultaneous research on several drugs and to contextualize answers based on patient data
- Check & Visit — In Brittany, in Rennes Check & Visit was born from the desire to help the owners of the whole world to realize the conditions of their apartment. In France each year, there are over 3,400,000 inventories made. For the 2,500,000 owners, which they are part of it is not always easy to make the inventory of his apartment. Whether due to lack ofavailability, legal knowledge, or the reliability of paper status reports. The inventory quickly becomes a tedious and time-consuming task that any owner would like to do without.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
XAnge is a BCorp-certified early-stage investment fund managing €700 million, with offices in Paris, Berlin, and Brussels. The fund backs European founders who aim to transform daily life through technology, investing between €500,000 and €10 million from the seed stage onwards. XAnge’s investment focus spans deeptech, health, fintech, SaaS, and e-commerce, with a portfolio including Lydia, Welcome to the Jungle, Believe, MrSpex, and Ledger. XAnge is the innovation-driven venture capital brand of the Siparex Group.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 243
- Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$75M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $261M in 2021
Portfolio highlights
- ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
- Procuros — More and more sales teams struggle with supplier portals. We help you integrate digitally with common supplier portals and consolidate all order documents.
- Intent Technologies — Intent Technologies provides a dedicated service platform for real estate players that allows them to optimize the operation of a heritage and build and distribute their services. The platform integrates a growing connected ecosystem including real estate managers (social and private landlords, trustee, real estate, communities, etc.), serviceproviders (facility management, energy, elevators, personal services, insurance, etc.), publishers business software (BIM, ERP, CRM, CMMS, BI, etc.) and IoT solution providers.
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able to count on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Private Equity, Series A, Seed
- Geography: France, Spain, Canada
Investor stats
- Total investments: 109
- Round size: Seed $1.5M–$5.8M; Series A $3.2M–$33M; Private Equity $3.2M–$49M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $39M in 2021
Portfolio highlights
- FINASENS — FINASENS provides consulting services in financial management and operational support for businesses and other organizations. The company focuses on outsourced chief financial officer services, helping clients manage budgeting, reporting, cash management, and financial planning. FINASENS assists mid-sized and small companies that need structuredfinancial direction without building a full internal finance department. Its consultants also contribute to operational improvement projects related to finance processes and management control. FINASENS engages on a recurring or project basis depending on client needs and scope of work.
- Archeon — Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care.
- B Capital Partners — B Capital Partners is a financial services firm offering investment advisory solutions with a focus on infrastructure and clean energy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Octalfa is a France-based venture capital firm that offers a range of financial services.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 20
- Round size: Seed $658k–$4.6M; Venture - Series Unknown $1.9M–$2.4M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.
- Ventuno Biotech — Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to
Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.
Show more...Investment focus
- Industry: Manufacturing, Software, AgTech
- Stage:Seed, Series A
- Geography: France, Germany, Slovenia
Investor stats
- Total investments: 100
- Round size: Seed $1.5M–$6M; Series A $6.4M–$27M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $53M in 2018
Portfolio highlights
- Jay&Joy — Jay&Joy is the first plant-based creamery in France engaged in manufacturing alternatives to cheese made from almond milk and cashew nuts.
- Quideos — Quideos is an agriculture based platform that ensures secured purchase and sale of agricultural raw materials.
- Phase One Lionheart — VER GEO LIO GmbH ("PhaseOneCo") is an indirect subsidiary of Vulcan Energy Resources Limited.
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Venture - Series Unknown, Series A
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Series A $849k–$7.2M; Venture - Series Unknown $1.3M–$11M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $26M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 82
- Round size: Seed $137k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $2M–$16M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 16
- Round size: Series A $6.1M–$74M; Series B $10M–$80M; Venture - Series Unknown $1.8M–$12M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Caisse d’Epargne is a cooperative bank that supports all economic players. It shares its values of social responsibility and humanism with its member customers. It is committed to the heart of the regions, the 15 regional savings banks are involved on a daily basis in their clients' projects and provide them with tailor-made solutions.Ithas now had 4.8 million members and 20.6 million customers, managed by 4,182 bank branches and the My Online Banker branch.It was created in 1818 and is headquartered in Paris, France.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Seed
- Geography: France
Investor stats
- Total investments: 51
- Round size: Seed $400k–$4.4M; Debt Financing $445k–$169M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Calicéo — Calicéo operates as a family group of aquatic fitness and beauty-massage spaces.
- Leanspace — Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources.Leanspace brings a new wayto build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness.Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!
- Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
High Tech, Low Carbon: crafting tomorrow, today. We finance innovation to make tomorrow happen today. Starquest is a Montefiore Company.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Singapore, United States
Investor stats
- Total investments: 116
- Round size: Seed $300k–$2.5M; Series A $1.2M–$11M; Venture - Series Unknown $448k–$20M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fresh fund, raised $200k in 2026
Portfolio highlights
- Heliup — Heliup is a company that creates and manufactures solar systems for huge building roofs for commercial and industrial buildings.
- Cailabs — Cailabs is a global leader in free-space optical communications. Its dual-use Optical Ground Stations (OGS) are deployed worldwide by leading satellite operators and agencies such as SES, ESA and Contec. The company is among the very few globally to have demonstrated satellite-to-ground links fully compliant with the US Space Development Agency(SDA) standard, confirming its unique technological position.It also plays a central role in European sovereignty/defense programs such as Keraunos, developing secure OGS for next-generation optical satellite links.Founded in 2013, Cailabs has raised over €100M and grown to 170 employees (as of Dec 2025). Cailabs has a global presence with 3 offices : its HQ based in Rennes (Brittany, France), 1 office in Paris (France) and 1 office in Washington DC (Arlington, VA).
- Eurodia — Eurodia is a designer, manufacturer, and assembler of industrial solutions for the purification of fluids. They provide liquid purification industrial processes combining electrodialysis, chromatography, ion exchange systems, and membrane filtration. They provide these tools for the dairy and cheese industries, the sugar and wine industries, andthe field of energy and ecological transition. They provide electrodialysis technology, bipolar membrane electrodialysis, membrane filtration, and much more.
Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential. The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources and Ecotechnologies. Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies. Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 44
- Round size: Seed $513k–$3.4M; Series A $530k–$18M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Pikkopay — Pikkopay provides a mobile payment solution that transforms customer smartphones into cash registers. Customers can scan items, pay, and go, eliminating the need for traditional checkout lines. The service aims to streamline the shopping experience and increase user retention rates. Pikkopay is designed to save time for both customers andretailers, offering a hassle-free shopping experience.
- StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
- Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 305
- Round size: Seed $1.2M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $61M in 2022
Portfolio highlights
- Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
- Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
- Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 676
- Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
- Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities. This brings visibility and confidence for entrepreneurs as well as for its investors. Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.
Show more...Investment focus
- Industry: Energy, Electronics, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: France, Canada, Switzerland
Investor stats
- Total investments: 30
- Round size: Seed $1.5M–$3.3M; Series A $1.4M–$6.8M; Venture - Series Unknown $566k–$6M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $78M in 2008
Portfolio highlights
- SENCROP — Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making moreefficient and sustainable farming possible
- Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.
- MESA Imaging — MESA Imaging is focusing on the development and production of 3D time-of-flight cameras.
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Industry: Health Care, Software, Food and Beverage
- Stage:Venture - Series Unknown, Seed
- Geography: France, United States, Canada
Investor stats
- Total investments: 113
- Round size: Seed $1.1M–$5.4M; Venture - Series Unknown $1.2M–$5.6M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Haiku — Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law. The company's objective is to free lawyers from tedious research and writing tasks to assist them in all of their work and thus increase their productivity while preserving their expertise.
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
- Ascendance — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more...Investment focus
- Industry: Software, Internet, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 73
- Round size: Seed $325k–$1.7M; Venture - Series Unknown $1.1M–$5.7M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
- SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
- C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: France, United States
Investor stats
- Total investments: 14
- Round size: Series A $16M–$21M; Series B $14M–$21M; Series C $18M–$26M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
- Diotheris — Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria. The company's products are based on live bacteria includes NASOFLORE which targets Staphylococcus aureus, enabling the prevention of infections due to major pathogen and protecting patients against biologicalthreats.
- AlgoTherapeutix — AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
Venture capital for companies developing innovative therapeutics.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series A, Series B, Series C
- Geography: France, Switzerland, United States
Investor stats
- Total investments: 37
- Round size: Series A $12M–$123M; Series B $7.1M–$100M; Series C $22M–$125M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $205M in 2020
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- NovaGo Therapeutics — NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. A strategic partnership with Neurimmune provides access to a unique class of human-derived antibodies with exceptional therapeutic propertiesgenerated through their Reverse Translational Medicine™ (RTM™) technology platform.
- PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages. We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+ portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders. Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Venture - Series Unknown
- Geography: France, United States, Belgium
Investor stats
- Total investments: 109
- Round size: Series A $3.4M–$26M; Venture - Series Unknown $1.9M–$24M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- e-peas — Discover e-peas, pioneer of the Ambient IoT concept since 2014, which offers the most efficient energy harvesting pmics on the market to make your devices more energy self-sufficient: AEMs.
- Ever Dye — A new standard for dyes. Naturally made, carbon emissions reducing, water protecting.
- Standing Ovation — Animal-free dairy cheese
CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.
Show more...Investment focus
- Industry: Manufacturing, Energy, Biotechnology
- Stage:Seed, Series A
- Geography: France, Canada, United States
Investor stats
- Total investments: 45
- Round size: Seed $847k–$21M; Series A $1.4M–$13M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $50M in 2013
Portfolio highlights
- iNGage — iNGage is a manufacturer of high-performance inertial MEMS navigation sensors for high-volume autonomous mobility markets
- STELLARIA — Stellaria is a 200 MWe molten salt reactor with 20-year autonomy, delivering safe, sustainable nuclear power without refueling.
- STELLARIA — Stellaria is reimagining sustainable rapid neutron nuclear energy.
HCVC backs founders on a mission to industrialize scientific and technological progress.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Robotics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 102
- Round size: Seed $1.4M–$11M; Pre-Seed $1.4M–$5.2M; Series A $5.2M–$30M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $75M in 2023
Portfolio highlights
- NavierAI — Design, simulate, and code in one platform, driven by agents. In Prism, an engineering agent plans the work, runs your solvers, and reports back.
- Rivercell — Rivercell develops a proprietary, programmable laboratory data platform alongside an artificial intelligence world model of the human cell to map and analyze therapeutic cellular responses. The integrated framework combines automated longitudinal, multimodal, and perturbational wet-lab testing to collect high-resolution datasets measuring how living tissue changes over time under specific treatments. Its value proposition is centered on serving as a cross-disease discovery engine that accelerates and de-risks drug development by accurately forecasting cellular mutations, clinical efficacy, and treatment resistance in silico.
- Chiral — Next-generation electronics with nanomaterials
Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United States, Canada
Investor stats
- Total investments: 208
- Round size: Seed $1.1M–$5M; Series A $1.4M–$15M; Venture - Series Unknown $850k–$8.4M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $65M in 2023
Portfolio highlights
- Moodwork — Moodwork provides a digital platform for workplace mental health that combines AI with human expertise to support employees through assessments, guidance, and access to professional resources. The platform also delivers anonymized workforce insights, enabling organizations to monitor mental health trends, protect employee privacy, and supportinformed workplace decisions.
- AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
- Discernis — Home | Discernis AI-Native Discovery
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.3M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Biotech Investor funding in France at a glance
Stats across 1.5k deals from 1.3k investors.
Access all 1287 investors in France Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1287 investors investing in France Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!